ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,766,155, issued on Oct. 20, was assigned to University of South Florida (Tampa, Fla.).
"Methods of decreasing heparan sulfate expression using EXT1 inhibitors" was invented by Lianchun Wang (Tampa, Fla.).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides for a method of decreasing heparan sulfate expression in a subject in need thereof, the method comprising administering an inhibitor of EXT1 gene expression, wherein the inhibitor comprises a therapeutically effective amount of vitamin D. Further provided herein, is a method of treating cancer in a subject in need thereof, the method comprising administering an inhibitor of EX...